A new tooth-regrowing drug has finally entered human trials after months of waiting and promising clinical trials on mice and ...

A once-groundbreaking sickle cell disease drug — at the center of a $5.4 billion acquisition two years ago — is the subject ...

About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.

Patients with disability often face considerable barriers when it comes to accessing clinical trials for new drugs and ...

Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, named VU319, is the first end-to-end drug discovery ...

T he US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to a cancer drug called dostarlimab ...

Adverse drug reactions (ADRs) remain a common clinical problem since they can mimic many diseases and cause significant morbidity and mortality. Judicious prescribing is important to minimize ...

Pyxis Oncology is shelving a clinical-stage monoclonal antibody to focus on its lead antibody-drug conjugate (ADC) after ...

(Reuters) -BioNTech SE said on Friday it has been informed by its partner OncoC4 that the U.S. Food and Drug Administration ...

From pig kidney transplants to the development of a new schizophrenia drug, here are five of the biggest medical ...

Prothena's stock soared 34% despite setbacks, with promising partnerships and potential in Parkinson's and Alzheimer's ...

More than 100 locations nationwide are participating in new clinical trials for a drug that shows promise for treating epileptic seizures among patients for whom other medications do not work.